Study finds 84% survival rate in patients in cardiogenic shock and other challenging cardiac conditions with the new impella 5.5 with smartassist

The first published united states experience of patients who received abiomed’s newest heart pump, impella 5.5 with smartassist, finds 84% of the pati

ABMD Ratings Summary

ABMD Quant Ranking